+

WO2008010008A3 - Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine - Google Patents

Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine Download PDF

Info

Publication number
WO2008010008A3
WO2008010008A3 PCT/IB2006/002252 IB2006002252W WO2008010008A3 WO 2008010008 A3 WO2008010008 A3 WO 2008010008A3 IB 2006002252 W IB2006002252 W IB 2006002252W WO 2008010008 A3 WO2008010008 A3 WO 2008010008A3
Authority
WO
WIPO (PCT)
Prior art keywords
cardiovascular
rennin
combinations
inhibitors
angiotensin inhibitors
Prior art date
Application number
PCT/IB2006/002252
Other languages
English (en)
Other versions
WO2008010008A2 (fr
Inventor
Eswaran Krishnan Iyer
Rasendra Kumar Jayantilal Jha
Girish Kumar Jain
Parag Borde
Narayanan Murli
Original Assignee
Wockhardt Ltd
Eswaran Krishnan Iyer
Rasendra Kumar Jayantilal Jha
Girish Kumar Jain
Parag Borde
Narayanan Murli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd, Eswaran Krishnan Iyer, Rasendra Kumar Jayantilal Jha, Girish Kumar Jain, Parag Borde, Narayanan Murli filed Critical Wockhardt Ltd
Priority to PCT/IB2006/002252 priority Critical patent/WO2008010008A2/fr
Publication of WO2008010008A2 publication Critical patent/WO2008010008A2/fr
Publication of WO2008010008A3 publication Critical patent/WO2008010008A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouvelles compositions pharmaceutiques, leur procédé de préparation et l'utilisation de ces compositions, lesquelles sont administrées comme polythérapie pour le traitement d'affections cardiovasculaires et de troubles associés, notamment sous la forme d'une combinaison d'antagonistes de l'angiotensine II, de régulateurs lipidiques (inhibiteurs de HMG-CoA réductase), d'inhibiteurs de l'agrégation plaquettaire et de diurétiques.
PCT/IB2006/002252 2006-07-17 2006-07-17 Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine WO2008010008A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/002252 WO2008010008A2 (fr) 2006-07-17 2006-07-17 Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/002252 WO2008010008A2 (fr) 2006-07-17 2006-07-17 Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine

Publications (2)

Publication Number Publication Date
WO2008010008A2 WO2008010008A2 (fr) 2008-01-24
WO2008010008A3 true WO2008010008A3 (fr) 2009-04-16

Family

ID=38957139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/002252 WO2008010008A2 (fr) 2006-07-17 2006-07-17 Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine

Country Status (1)

Country Link
WO (1) WO2008010008A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054123A1 (fr) * 2006-10-30 2008-05-08 Hanall Pharmaceutical Company, Ltd. Composition complexe à libération contrôlée comprenant des bloqueurs des récepteurs de l'angiotensine ii et des inhibiteurs de la hmg-coa réductase
EP2180891A4 (fr) * 2007-08-13 2010-12-29 Hanall Biopharma Co Ltd Préparation combinée contenant un inhibiteur de hmg-coa reductase et aspirine et son procédé d'élaboration
KR101248804B1 (ko) * 2010-05-14 2013-03-29 한미사이언스 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제 및 이베살탄을 포함하는 이층정 약제학적 복합제제
BR102012020648A2 (pt) * 2012-08-17 2014-12-09 Hypermarcas S A Preparação farmacêutica oral sólida para a prevenção de doença cardio e cerebrovasculares e comprimido
KR20140030505A (ko) * 2012-08-31 2014-03-12 한미약품 주식회사 이베살탄 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제
CN105232484A (zh) * 2015-09-24 2016-01-13 青岛华之草医药科技有限公司 一种解热、镇痛、抗炎药物阿司匹林组合物片剂
EP3342400A1 (fr) * 2016-12-31 2018-07-04 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Composition pharmaceutique comprenant de la valsartane et du chlorthalidone

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259925A1 (en) * 2003-01-16 2004-12-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
US20050080071A1 (en) * 2001-01-26 2005-04-14 Davis Harry R. Treatment methods
US20050085511A1 (en) * 2003-10-08 2005-04-21 Qiao Jennifer X. Cyclic diamines and derivatives as factor Xa inhibitors
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080071A1 (en) * 2001-01-26 2005-04-14 Davis Harry R. Treatment methods
US20040259925A1 (en) * 2003-01-16 2004-12-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions and methds for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
US20050085511A1 (en) * 2003-10-08 2005-04-21 Qiao Jennifer X. Cyclic diamines and derivatives as factor Xa inhibitors
US20050209288A1 (en) * 2004-01-12 2005-09-22 Grogan Donna R Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use

Also Published As

Publication number Publication date
WO2008010008A2 (fr) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2010003127A3 (fr) Antagonistes des récepteurs de la prostaglandine d<sb>2</sb>
WO2010127099A3 (fr) Compositions pharmaceutiques comprenant de l'epa et un agent cardiovasculaire et leurs procédés d'utilisation
WO2010037059A3 (fr) Antagonistes hétéroaryliques des récepteurs de prostaglandine d<sb>2</sb>
WO2009108720A3 (fr) Antagonistes des récepteurs d2 de la prostaglandine
WO2010057118A3 (fr) Antagonistes hétérocycliques des récepteurs de la prostaglandine d2
WO2009145989A3 (fr) Antagonistes d’aminoalkylphényle de récepteurs de prostaglandine d<sb>2</sb>
WO2010039977A3 (fr) Antagonistes d'hétéroaryle des récepteurs de la prostaglandine d2
WO2010054113A3 (fr) Antagonistes de cycloalkane[b]azaindole de récepteurs de la prostaglandine d2
WO2007127505A3 (fr) Composés chimiques
WO2008148074A3 (fr) Inhibiteurs de mtor et methodes de traitement mettant en œuvre ces inhibiteurs
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
WO2010042652A3 (fr) Antagonistes hétéroalkyl biphényle des récepteurs de la prostaglandine d2
WO2012080727A3 (fr) Inhibiteurs de caséine kinase 1 delta (ck1delta)
WO2010008864A3 (fr) Antagonistes de cycloalcane[b]indole de récepteurs de prostaglandine d2
WO2008010222A3 (fr) Conjugués innovants, compositions pharmaceutiques les comprenant et leurs utilisations
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
WO2008115974A3 (fr) Analogues de pyrazolopyrimidine et leur utilisation en tant qu'inhibiteurs de kinase mtor et kinase pi3
WO2009121872A3 (fr) Tétrahydroisoquinoléines, compositions pharmaceutiques les contenant et leur utilisation en thérapie
MY144857A (en) Phamaceutical composition comprising amlodipine and losartan
WO2009121039A3 (fr) Administration de compositions de benzodiazépine
WO2009010810A3 (fr) Associations cardiovasculaires comprenant des inhibiteurs de l'ace et de l'hmg-co-a
WO2006010423A3 (fr) Nouveaux composes d'azaindole inhibiteurs de mtp et d'apob
WO2008010008A3 (fr) Combinaisons cardiovasculaires faisant appel à des inhibiteurs de rennine-angiotensine
WO2011150201A3 (fr) Composés azolylamide et leurs procédés d'utilisation
WO2008097924A3 (fr) Compositions pharmaceutiques comprenant des analogues du dextrométhorphane pour le traitement de troubles neurologiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06795278

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06795278

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载